Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 6 of 15
Arctoris
Arctoris
Future Planet Fund I
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
2019
Hold
7yr
Argobio
Argobio
Angelini Ventures
France
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
ArkVax
ArkVax
UK Innovation and Science Seed Fund
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
2022
Hold
4yr
ArsenalBio
ArsenalBio
Hitachi Ventures Fund II
United States
Active
Sector
Biotech
InvestorHitachi Ventures
Entry
2022
Hold
4yr
Artax Biopharma
Artax Biopharma
Columbus Innvierte Life Science Fund I
United States
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2020
Hold
6yr
Ascend Advanced Therapies
Ascend Advanced Therapies
4BIO Ventures III
UK
Active
Sector
Biotech
Investor4Bio Partners
Entry
2023
Hold
3yr
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Abingworth Bioventures 8
UK
Active
Sector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
AstronauTx
AstronauTx
Dementia Discovery Fund
UK
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
Atlas Molecular Pharma
Atlas Molecular Pharma
Inveready Biotech III
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2021
Hold
5yr
Atrandi Biosciences
Atrandi Biosciences
Vsquared Ventures II
Lithuania
Active
Sector
Biotech
InvestorVsquared Ventures
Entry
2025
Hold
1yr
AudioCure
AudioCure
HTGF II
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2012
Hold
14yr
Aurobac Therapeutics
Aurobac Therapeutics
Boehringer Ingelheim Venture Fund
France
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Auron Therapeutics
Auron Therapeutics
Apollo Health Ventures Fund II
United States
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
Avantea
Avantea
Taste of Italy 2
Italy
Active
Sector
Biotech
InvestorDeA Capital Alternative Funds SGR
Entry
2024
Hold
2yr
Awen Oncology
Awen Oncology
Development Bank of Wales (Balance Sheet)
UK
Active
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2024
Hold
2yr
Axovia Therapeutics
Axovia Therapeutics
ALSA Ventures European Biotechnology Fund
UK
Active
Sector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
Barinthus Biotherapeutics
Barinthus Biotherapeutics
Future Planet Fund I
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
2020
Hold
6yr
Baseimmune
Baseimmune
IQ Capital Fund III
UK
Active
Sector
Biotech
InvestorIQ Capital Partners
Entry
2021
Hold
5yr
Batea Oncology, S.L.
Batea Oncology, S.L.
SODIGA Galicia
Spain
Active
Sector
Biotech
InvestorXesGalicia
Entry
2025
Hold
1yr
BDI Biotech
BDI Biotech
Inveready Biotech II
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
9yr
Beacon Therapeutics
Beacon Therapeutics
Oxford Science Enterprises Balance Sheet
UK
Active
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2023
Hold
3yr
Bicycle Therapeutics
Bicycle Therapeutics
CIC Fund I
UK
Active
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2016
Hold
10yr
Bindbridge
Bindbridge
Nucleus Capital II
United Kingdom
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
BioAscent
BioAscent
Maven Income and Growth VCT 4
UK
Active
Sector
Biotech
InvestorMaven Capital Partners
Entry
2018
Hold
8yr
Biocross
Biocross
ADE Capital Sodical
Spain
Active
Sector
Biotech
InvestorSodical
Entry
2011
Hold
15yr
Biomatter
Biomatter
UVC Fund IV
Lithuania
Active
Sector
Biotech
InvestorUnternehmertum Venture Capital Partners
Entry
2024
Hold
2yr
Biomia
Biomia
Nucleus Capital I
Denmark
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2023
Hold
3yr
bioXXmed AG
bioXXmed AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Germany
Active
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2024
Hold
2yr
bit.bio
bit.bio
BlueYard Capital Fund II
United Kingdom
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2019
Hold
7yr
Bitrobius Genetics
Bitrobius Genetics
UK Innovation and Science Seed Fund
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
2023
Hold
3yr
BiVictriX Therapeutics
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
UK
Active
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2016
Hold
10yr
Bota Bio
Bota Bio
BASF Venture Capital Evergreen Fund
China
Active
Sector
Biotech
InvestorBASF Venture Capital
Entry
2021
Hold
5yr
Bright Biotech
Bright Biotech
FoodLabs Fund II
United Kingdom
Active
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Bright Peak Therapeutics
Bright Peak Therapeutics
TVM Life Science Ventures
Switzerland
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Broken String
Broken String
DvH Ventures Fund IV (Digital Health Fund)
Germany
Active
Sector
Biotech
InvestorDvH Ventures
Entry
2021
Hold
5yr
Capricorn Scientific GmbH
Capricorn Scientific GmbH
Hessen Kapital
Germany
Active
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
CaSRevolution
CaSRevolution
Utopia SIS
Italy
Active
Sector
Biotech
InvestorUtopia SIS
Entry
2023
Hold
3yr
Cebiotex
Cebiotex
Inveready Biotech II
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Celea Therapeutics
Celea Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2026
Hold
0yr
CellCentric
CellCentric
UK Innovation and Science Seed Fund
UK
Active
Sector
Biotech
InvestorFuture Planet Capital
Entry
CellDrive
CellDrive
BeAble Innvierte KETs Fund
Spain
Active
Sector
Biotech
InvestorBeAble Capital
Entry
2021
Hold
5yr
Cellino Biotech
Cellino Biotech
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Centauri Therapeutics
Centauri Therapeutics
Boehringer Ingelheim Venture Fund
United Kingdom
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2022
Hold
4yr
Cerevance
Cerevance
Dementia Discovery Fund
United States
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2016
Hold
10yr
Change Foods
Change Foods
Green Generation Fund I
United States
Active
Sector
Biotech
InvestorGreen Generation Fund
Entry
2022
Hold
4yr
Cimico
Cimico
Moira Capital Desarrollo
Spain
Active
Sector
Biotech
InvestorMoira Capital Partners
Entry
2023
Hold
3yr
Cleara Biotech
Cleara Biotech
Apollo Health Ventures Fund II
Netherlands
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
clock.bio
clock.bio
BlueYard Capital Fund III
United Kingdom
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Cocoon Bioscience
Cocoon Bioscience
Columbus Life Sciences Fund IV
Spain
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Code Biotherapeutics
Code Biotherapeutics
4BIO Ventures III
US
Active
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr